Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue

Precision oncology based on specific molecular alterations requires precise and reliable detection of therapeutic targets in order to initiate the optimal treatment. In many European countries—including Germany—assays employed for this purpose are highly diverse and not prescribed by authorities, ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollbrecht, Claudia, Hoffmann, Inga, Lehmann, Annika, Merkelbach-Bruse, Sabine, Fassunke, Jana, Wagener-Ryczek, Svenja, Ball, Markus, Dimitrova, Lora, Hartmann, Arndt, Stöhr, Robert, Erber, Ramona, Weichert, Wilko, Pfarr, Nicole, Bohlmann, Lisa, Jung, Andreas, Dietmaier, Wolfgang, Dietel, Manfred, Horst, David, Hummel, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067656/
https://www.ncbi.nlm.nih.gov/pubmed/36367572
http://dx.doi.org/10.1007/s00428-022-03445-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067656/
https://www.ncbi.nlm.nih.gov/pubmed/36367572
http://dx.doi.org/10.1007/s00428-022-03445-x

Ejemplares similares